Microvascular and Inflammatory Responses of 0.05 Cyclosporine Eye Drop (II) in Treatment of Dry Eye
Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
To explore the law of changes in ocular surface inflammation when 0.05% cyclosporine eye
drops (II) is used to treat dry eye, 50 cases of mild to moderate dry eyes were included. The
expectation is finding out whether cyclosporine has a regulatory effect on conjunctival
microvascular parameters and other inflammation indicators after cyclosporine eye drops treat
dry eye, and analyze the value of conjunctival microvascular indicators in dry eye
immunosuppressive therapy.
Phase:
N/A
Details
Lead Sponsor:
Zhongshan Ophthalmic Center, Sun Yat-sen University